CYTONUS THERAPEUTICS INC.
CYTONUS THERAPEUTICS INC. is a federal contractor, registered under UEI UBM9DERRCXZ9 and CAGE code 8DAU4. It has been awarded $5,046,082 across 7 federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Health And Human Services and Department Of Defense (dod).
Contact Information
Registration and classification details
Registration
UEI Code
UBM9DERRCXZ9CAGE Code
8DAU4Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
CYTONUS THERAPEUTICS INC. specializes in advanced therapeutic research and development, with core capabilities centered on biopharmaceutical innovation, preclinical drug discovery, and translational medicine. The company leverages molecular biology, pharmacokinetic modeling, and targeted delivery sy...
CYTONUS THERAPEUTICS INC. specializes in advanced therapeutic research and development, with core capabilities centered on biopharmaceutical innovation, preclinical drug discovery, and translational medicine. The company leverages molecular biology, pharmacokinetic modeling, and targeted delivery systems to advance novel therapeutic candidates from concept to investigational new drug status. Technical expertise includes cell-based assay development, biomarker identification, and GMP-compatible process scaling for biologics and small-molecule compounds. Their differentiation lies in integrating precision medicine approaches with proprietary platforms for patient stratification and mechanism-of-action validation, enabling efficient de-risking of early-stage candidates. While no award history is available to confirm specific federal engagements, the firm’s NAICS classification of 541714 indicates a focus on research and development in the life sciences, particularly in pharmaceutical and therapeutic innovation. No agency relationships can be inferred due to absence of contract data. The company’s market positioning is aligned with the federal biomedical research ecosystem, serving as a potential partner for agencies advancing next-generation therapies, including NIH, BARDA, and DoD medical research programs. CYTONUS THERAPEUTICS INC. is structured as a small business (2L) with its primary operations based in Columbus, Ohio. The firm holds no government certifications, and its geographic presence is limited to its Ohio location. Without documented contract performance, its government market footprint remains undeclared, though its technical profile suggests alignment with NIH-funded translational research initiatives and defense medical innovation pipelines.
Key Performance Metrics
Awards Count
All time
Active
Currently performing
Completed
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
